Mirtazapine increases dopamine release in prefrontal cortex by 5-HT1A receptor activation
- 1 April 2004
- journal article
- Published by Elsevier in Brain Research Bulletin
- Vol. 63 (3) , 237-241
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- A double-blind, placebo-controlled study of antidepressant augementation with mirtazapineBiological Psychiatry, 2002
- Mirtazapine enhances frontocortical dopaminergic and corticolimbic adrenergic, but not serotonergic, transmission by blockade of α2‐adrenergic and serotonin2C receptors: a comparison with citalopramEuropean Journal of Neuroscience, 2000
- Ipsapirone enhances the dopamine outflow via 5-HT1A receptors in the rat prefrontal cortexEuropean Journal of Pharmacology, 1996
- Chronic desipramine and fluoxetine differentially affect extracellular dopamine in the rat prefrontal cortexPsychopharmacology, 1996
- Noradrenergic modulation of central serotonergic neurotransmission: acute and long-term actions of mirtazapineInternational Clinical Psychopharmacology, 1995
- P-2-93 Down regulation of 5-HT2A receptors after chronic treatment with remeronEuropean Neuropsychopharmacology, 1995
- The 5-HT1A receptor selective ligands, (R)-8-OH-DPAT and (S)-UH-301, differentially affect the activity of midbrain dopamine neuronsNaunyn-Schmiedeberg's Archives of Pharmacology, 1993
- Reduction of Prefrontal Cortex Glucose Metabolism Common to Three Types of DepressionArchives of General Psychiatry, 1989
- Frontal cortex and basal ganglia metabolic rates assessed by positron emission tomography with [18F]2-deoxyglucose in affective illnessJournal of Affective Disorders, 1986
- Regulation of dopamine release by impulse flow and by autoreceptors as studied by in vivo voltammetry in the rat striatumNeuroscience, 1985